Hui Xiong

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

Basil T. Darras, Riccardo Masson, Maria Mazurkiewicz-Bełdzińska et al. · New England Journal of Medicine · 2021 · 262 citations · Full text

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

Tamara Dangouloff, Eva Vrščaj, Laurent Servais et al. · Neuromuscular Disorders · 2021 · 164 citations

Early Diagnosis, Rare Diseases, Newborn Screening +7

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 96 citations · Full text

Type 1, Firefish Part 2, Rehabilitation +6

Genotype/phenotype analysis in Chinese laminin‐α2 deficient congenital muscular dystrophy patients

Hui Xiong, Dandan Tan, S. Wang et al. · Clinical Genetics · 2014 · 71 citations

Clinical study and <i>PLA2G6</i> mutation screening analysis in Chinese patients with infantile neuroaxonal dystrophy

Yan Wu, Yuwu Jiang, Zhijie Gao et al. · European Journal of Neurology · 2008 · 55 citations · Full text